Patent details

Basic Information

Publication number:

EP3388111

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP181748179

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

ORGANOARSENIC COMPOUND FOR THE TREATMENT OF CANCER

French Title of Invention:

COMPOSÉ ORGANOARSÉNIQUE POUR LE TRAITEMENT D'UN CANCER

German Title of Invention:

ORGANOARSENISCHE VERBINDUNG ZUR BEHANDLUNG VON KREBS

SPC Number:

Dates

Filing date:

14/08/2009

Grant date:

29/09/2021

EP Publication Date:

17/10/2018

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

29/09/2021

EP B1 Publication Date:

29/09/2021

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

14/08/2022

Expiration date:

14/08/2029

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

22/09/2021

 

 

Name:

Solasia Pharma K.K.

Address:

4F, Sumitomo Fudosan Shiba-koen Tower 2-11-1 Shiba-koen Minato-ku, Tokyo 105-0011, Japan (JP)

Inventor

1

Name:

SCHWARTZ, Brian, Eric

Address:

United States (US)

2

Name:

LEWIS, Jonathan

Address:

United States (US)

3

Name:

KOMARNITSKY, Philip, B.

Address:

United States (US)

Priority

Priority Number:

189511 P

Priority Date:

20/08/2008

Priority Country:

United States (US)

Classification

IPC classification:

A61P 35/00; A61K 31/455; A61K 38/06; A61K 31/285; A61K 31/60;

Publication

European Patent Bulletin

Issue number:

202139

Publication date:

29/09/2021

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages